Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 563 entries
View as:

Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03707457 Org: User:
Start: 03/22/19 End: 06/18/20 Due: 06/18/21

A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05574712 Org: User:
Start: 01/01/24 End: 07/31/26 Due: 07/31/27

Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02648282 Org: User:
Start: 07/18/16 End: 06/01/22 Due: 06/01/23

Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD

Phase: N/A Priority: Normal
NCT ID: NCT00278200 Org: User:
Start: 01/31/03 End: 08/31/12 Due: 08/31/13

Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System

Phase: N/A Priority: Normal
NCT ID: NCT00681304 Org: User:
Start: 08/31/07 End: 07/31/12 Due: 07/31/13

Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03793543 Org: User:
Start: 03/27/19 End: 10/15/21 Due: 10/15/22

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01666353 Org: User:
Start: 04/16/12 End: 12/04/18 Due: 12/04/19

Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)

Phase: N/A Priority: Normal
NCT ID: NCT01845805 Org: User:
Start: 01/10/14 End: 04/09/21 Due: 04/09/22

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00003176 Org: User:
Start: 03/25/98 End: 01/06/04 Due: 01/06/05

Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT01578551 Org: User:
Start: 05/31/12 End: 01/31/17 Due: 01/31/18

Head and Neck Cancer Treatment Related Dysphagia

Phase: N/A Priority: Normal
NCT ID: NCT02657850 Org: User:
Start: 06/09/16 End: 06/08/17 Due: 06/08/18

Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue

Phase: N/A Priority: Normal
NCT ID: NCT00982319 Org: User:
Start: 04/30/09 End: 11/30/13 Due: 11/30/14

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01937117 Org: User:
Start: 01/30/14 End: 06/30/26 Due: 06/30/27

Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01784081 Org: User:
Start: 04/30/14 End: 06/30/15 Due: 06/30/16

Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01296763 Org: User:
Start: 01/31/11 End: 02/29/16 Due: 02/28/17

A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia

Phase: N/A Priority: Normal
NCT ID: NCT01701375 Org: User:
Start: 09/30/12 End: 04/30/13 Due: 04/30/14

Skeletal Metastasis Registry

Phase: N/A Priority: Normal
NCT ID: NCT05058014 Org: User:
Start: 08/16/18 End: 12/06/23 Due: 12/06/24

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01431794 Org: User:
Start: 12/27/11 End: 11/05/18 Due: 11/05/19

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00006358 Org: User:
Start: 06/13/00 End: 07/20/06 Due: 07/20/07

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00003572 Org: User:
Start: 08/31/98 End: 04/30/02 Due: 04/30/03

Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00334542 Org: User:
Start: 03/31/06 End: 11/30/11 Due: 11/30/12

NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02833805 Org: User:
Start: 09/30/16 End: 07/31/21 Due: 07/31/22

Radiation and Androgen Ablation for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01517451 Org: User:
Start: 05/22/13 End: 12/31/26 Due: 12/31/27

UCN-01 in Treating Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003289 Org: User:
Start: 06/30/98 End: - Due: -

Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins

Phase: N/A Priority: Normal
NCT ID: NCT02965755 Org: User:
Start: 01/26/18 End: 07/31/26 Due: 07/31/27